ASB Consultores’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,069
Closed -$248K 143
2024
Q4
$248K Buy
+1,069
New +$246K 0.1% 172
2024
Q3
Sell
-1,276
Closed -$251K 213
2024
Q2
$251K Sell
1,276
-1,328
-51% -$274K 0.09% 168
2024
Q1
$561K Buy
+2,604
New +$547K 0.14% 106
2023
Q4
Sell
-1,795
Closed -$359K 121
2023
Q3
$359K Sell
1,795
-736
-29% -$146K 0.14% 69
2023
Q2
$469K Buy
2,531
+9
+0.4% +$1.66K 0.23% 81
2023
Q1
$483K Buy
2,522
+54
+2% +$9.77K 0.19% 75
2022
Q4
$415K Hold
2,468
0.17% 89
2022
Q3
$437K Sell
2,468
-174
-7% -$34.4K 0.21% 62
2022
Q2
$541K Buy
2,642
+154
+6% +$32.6K 0.24% 46
2022
Q1
$592K Sell
2,488
-210
-8% -$49.3K 0.25% 68
2021
Q4
$616K Buy
+2,698
New +$594K 0.3% 64

Other funds holding CME

ASB Consultores's CME Position: Q1 2025 in Review

ASB Consultores sold out of CME Group (CME) in Q1 2025, closing a stake of 1,069 shares — an estimated $248K sold.

ASB Consultores first reported a position in CME in Q4 2021 and held it in 11 quarters. The position peaked at $616K in Q4 2021. 1,596 funds tracked by Wall St. Rank hold CME as of Q1 2025.

  • ASB Consultores reported no remaining CME Group position as of Q1 2025 after selling out during the quarter.
  • ASB Consultores sold 1,069 CME Group shares in Q1 2025, an estimated $248K.
  • ASB Consultores first reported a position in CME Group in Q4 2021 and held it in 11 quarters.
  • ASB Consultores's CME Group position peaked at $616K in Q4 2021.
  • 1,596 funds tracked by Wall St. Rank held CME Group as of Q1 2025.

Based on ASB Consultores's 13F filing for Q1 2025, filed 13 May 2025.